Company · in the news since February 19, 2026
Vertex Pharmaceuticals news
Vertex Pharmaceuticals appeared in 9 news events on GetYourBrief between February 19, 2026 and September 3, 2026, on the Biotech, Healthcare and SaaS desks and 1 more. The latest: "FDA approves Casgevy gene therapy for children with sickle cell disease" (July 8, 2026).
- news events9
- days in the news9
- desks4
- outlets in the latest 9 events17
When was Vertex Pharmaceuticals in the news?
The latest news about Vertex Pharmaceuticals
- Jul 8 · Biotech FDA approves Casgevy gene therapy for children with sickle cell disease 1
- Jul 7 · AI AI stocks sink and drag markets lower worldwide 8
- Mar 14 · SaaS Seeking Alpha: “Highest and lowest quant-rated technology stocks above $10B cap after earnings season” 1
- Mar 11 · Biotech Seeking Alpha: “Cathie Wood buys the dip in gene-editing firm CRISPR Therapeutics” 1
- Mar 10 · Healthcare Vertex says kidney drug met goal in late-stage trial 1
- Feb 18 · Healthcare finanznachrichten.de: “Grünenthal Group: Grünenthal proprietary NaV 1.8 inhibitor enters clinical development” 2
Which desks cover Vertex Pharmaceuticals?
Which outlets cover Vertex Pharmaceuticals most?
Counted over the latest 9 events; one per outlet per event. Source: the reports linked on each event.
Who appears in the news with Vertex Pharmaceuticals?
Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).